Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Complications of atherosclerosis are the most common cause of death in Western societies. Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors. However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis. The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins. The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans. Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [18]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [101]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [44]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A simple fluorometric assay for lipoperoxide in blood plasma
Yagi, K. (1976) · Biochemical Medicine · doi:10.1016/0006-2944(76)90049-1 · Cited by 2,103 · cited 1×
“The concentrations of thiobarbituric-acid-reactive substance”
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“gif" NDATA ITEM> ]> Complications of atherosclerosis are the most common cause of death in Western societie”
BackgroundTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationBorén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · cited 1×
“The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycan”
BackgroundSelf-citationImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Cited by
Items 101–200 of 1,000
Waist Circumference, Visceral Obesity, and Cardiovascular Risk
Poirier, P., & Després, J.-P. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00001 · Cited by 158
Elmarasi, M., Elmakaty, I., Elsayed, B., Elsayed, A., Zein, J. A., Boudaka, A., & Eid, A. H. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31200 · Cited by 178
“These synthetic VSMCs are thought to be the predominant source of ECM in DITs during the preatherosclerotic stage, accounting for much of the increase in intimal thickness (Skålén et al., 2002).”
BackgroundMacrophages: An elusive yet emerging therapeutic target of atherosclerosis
Tiwari, R. L., Singh, V., & Barthwal, M. K. (2008) · Medicinal Research Reviews · doi:10.1002/med.20118 · Cited by 153
“PPARg phosphorylation mediated by MAPK facilitates foam cell formation in macrophages exposed to Ox-LDL.244 CD-36 also seems to be partially involved in insulin resistance observed in diabetes245 and metabolic syndrome is thought to increase susceptibility to atherosclerotic cardiovascular disease.”
BackgroundInfluentialLoss of Collagen XVIII Enhances Neovascularization and Vascular Permeability in Atherosclerosis
Moulton, K. S., Olsen, B. R., Sonn, S., Fukai, N., Zurakowski, D., & Zeng, X. (2004) · Circulation · doi:10.1161/01.cir.0000140720.79015.3c · Cited by 150
Liu, X., Ukai, T., Yumoto, H., Davey, M., Goswami, S., Gibson, F. C., & Genco, C. A. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.025 · Cited by 161
“Likewise, in a variety of animal models of atherosclerois, signs of inflammation occur hand-in-hand with incipient ipid accumulation in the artery wall [3,4].”
BackgroundCytokines and cardiovascular disease
Mehra, V. C., Ramgolam, V. S., & Bender, J. R. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405182 · Cited by 175
“Extracellular accumulation of lipids occurs early in response to increased plasma lipoprotein levels in animals [4].”
BackgroundAutoimmunity in atherosclerosis: a protective response losing control?
Nilsson, J. Å., & Hansson, G. K. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01945.x · Cited by 153
Pathophysiology and biochemistry of cardiovascular disease
Scott, J. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.04.012 · Cited by 153
Hiukka, A., Ståhlman, M., Pettersson, C., Levin, M., Adiels, M., Teneberg, S., Leinonen, E. S., Hultén, L. M., Wiklund, O., Orešič, M., et al. (2009) · Diabetes · doi:10.2337/db09-0206 · Cited by 141
“The binding of LDL to biglycan was assessed with a solid-phase assay using Maxisorp immunoplates (NUNC) coated with biglycan (28).”
MethodSelf-citationInflammation meets oxidation: NF-κB as a mediator of initial lesion development in atherosclerosis
Kütük, Ö., & Başağa, H. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.10.007 · Cited by 154
Mhaimeed, O., Burney, Z. A., Schott, S. L., Kohli, P., Marvel, F. A., & Martin, S. S. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100649 · Cited by 124
Nakano, M., Otsuka, F., Yahagi, K., Sakakura, K., Kutys, R., Ladich, E. R., Finn, A. V., Kolodgie, F. D., & Virmani, R. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht241 · Cited by 146
Lipoprotein Retention—and Clues for Atheroma Regression
Williams, K. J., & Tabas, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000174795.62387.d3 · Cited by 131
Pan, M., Maitin, V., Parathath, S., Andreo, U., Lin, S. X., Germain, C. S., Yao, Z., Maxfield, F. R., Williams, K. J., & Fisher, E. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707460104 · Cited by 128
Inflammation in Coronary Artery Disease
Christodoulidis, G., Vittorio, T. J., Fudim, M., Lerakis, S., & Kosmas, C. E. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000006 · Cited by 137
“This infiltration and retention of LDL in the arterial intima initiates an inflammatory response in the arterial wall.(4,5) Through oxidation and enzymatic attack of the LDL particles, phospholipids are released and subsequently activate the endothelial cells.”
BackgroundCanfrán‐Duque, A., Rotllán, N., Zhang, X., Andrés‐Blasco, I., Thompson, B. M., Sun, J., Price, N. L., Fernández‐Fuertes, M., Fowler, J. W., Gómez‐Coronado, D., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.059062 · Cited by 132
Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis
Fogelstrand, P., & Borén, J. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.09.007 · Cited by 154
Self-citationMäkinen, P. I., Lappalainen, J. P., Heinonen, S. E., Leppänen, P., Lähteenvuo, M., Aarnio, J., Heikkilä, J., Turunen, M. P., & Ylä‐Herttuala, S. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq235 · Cited by 146
Macrophages and Dendritic Cells: Partners in Atherogenesis
Cybulsky, M. I., Cheong, C., & Robbins, C. S. (2016) · Circulation Research · doi:10.1161/circresaha.115.306542 · Cited by 122
“Many studies have provided circumstantial evidence in support of the response to retention hypothesis, but perhaps the most convincing are functional data from transgenic mice showing that ApoB100 mutations that inhibit proteoglycan but not LDLR binding result in reduced arterial lipid accumulation.(91) Myeloid cells…”
BackgroundVladykovskaya, E., Sithu, S. D., Haberzettl, P., Wickramasinghe, N. S., Merchant, M. L., Hill, B. G., McCracken, J., Agarwal, A., Dougherty, S., Gordon, S. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.320416 · Cited by 126
“Extensive experimental and clinical evidence suggests that atherosclerosis begins with the subendothelial accumulation of lipoproteins in lesion-prone sites (1).”
BackgroundKarlsson, H., Leanderson, P., Tagesson, C., & Lindahl, M. (2005) · PROTEOMICS · doi:10.1002/pmic.200300938 · Cited by 126
Macrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 127
Flood, C., Gustafsson, M., Pitas, R. E., Arnaboldi, L., Walzem, R. L., & Borén, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000117174.19078.85 · Cited by 123
Self-citationMolecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis
Khalil, M. F., Wagner, W. D., & Goldberg, I. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000147163.54024.70 · Cited by 125
Actions of “antioxidants” in the protection against atherosclerosis
Lönn, M. E., Dennis, J. M., & Stocker, R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.027 · Cited by 130
“between apolipoprotein B-100 and proteoglycans decrease atherosclerosis in animals [19,20].”
Molecular structure of low density lipoprotein: current status and future challenges
Prassl, R., & Laggner, P. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0368-y · Cited by 139
“These distinct biophysical characteristics play an important role in determining the fate of LDL in the subendothelial space (Pentikainen et al. 2002; Skalen et al. 2002).”
BackgroundRabbani, N., Chittari, M. V., Bodmer, C. W., Zehnder, D., Ceriello, A., & Thornalley, P. J. (2010) · Diabetes · doi:10.2337/db09-1455 · Cited by 122
Bardini, G., Rotella, C. M., & Giannini, S. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.82 · Cited by 140
Immunomodulation of Atherosclerosis: Implications for Vaccine Development—ATVB In Focus
Nilsson, J., Hansson, G. K., & Shah, P. K. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000149142.42590.a2 · Cited by 122
Microstructured extracellular matrices in tissue engineering and development
Nelson, C. M., & Tien, J. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.08.011 · Cited by 127
“Many ECMs also play central roles in homeostasis [2], wound repair [10], and diseases such as atherosclerosis [11] and cancer [12,13], partly through mechanical alterations [14 ].”
BackgroundLiu, M., Reilly, M. P., Casasanto, P., McKenzie, S. E., & Williams, K. J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000254674.47693.e8 · Cited by 136
Shang, C., Lin, H., Fang, X., Wang, Y., Jiang, Z., Qu, Y., Xiang, M., Shen, Z., Xin, L., Lu, Y., et al. (2021) · Food & Function · doi:10.1039/d1fo01935j · Cited by 136
Animal Models of Atherosclerosis–Supportive Notes and Tricks of the Trade
Gisterå, A., Ketelhuth, D. F. J., Malin, S., & Hansson, G. K. (2022) · Circulation Research · doi:10.1161/circresaha.122.320263 · Cited by 138
CASLAKE, M. J., & Packard, C. J. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200308000-00002 · Cited by 119
Lipids and Lipoproteins in 2020
Ference, B. A., Kastelein, J. J. P., & Catapano, A. L. (2020) · JAMA · doi:10.1001/jama.2020.5685 · Cited by 147
Yeang, C., Witztum, J. L., & Tsimikas, S. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100053 · Cited by 124
“Transgenic mice expressing human apolipoprotein B-100 (hApoB) only and human-like LDL, because of a mutation in codon 2153 preventing apoB-48 synthesis, which were previously generated (9).”
BackgroundCSONT, T., BERECZKI, E., BENCSIK, P., FODOR, G., GORBE, A., ZVARA, A., CSONKA, C., PUSKAS, L., SANTHA, M., & FERDINANDY, P. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.006 · Cited by 117
“In accordance with previous studies [19,31] we have found an increased LDL cholesterol/HDL cholesterol ratio in the cholesterol-fed apoB-100 mice that is more characteristic for the human rather than the murine lipid profile.”
BackgroundHovland, A., Jonasson, L., Garred, P., Yndestad, A., Aukrust, P., Lappegård, K. T., Espevik, T., & Mollnes, T. E. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.038 · Cited by 117
“poproteins that are trapped and retained by matrix proteoglycans in the intimal layer of the arterial wall easily undergo oxidative modifications, and this event is followed by an immediate innate immune response [5,6].”
Öörni, K., Sneck, M., Brömme, D., Pentikäinen, M. O., Lindstedt, K. A., Mäyränpää, M. I., Aitio, H., & Kovanen, P. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310814200 · Cited by 133
Inflammation, infection and atherosclerosis
Shah, P. K. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.01.004 · Cited by 118
Serum amyloid A in atherosclerosis
King, V. L., Thompson, J., & Tannock, L. R. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283488c39 · Cited by 109
Souza, P., Marcadenti, A., & Portal, V. (2017) · Nutrients · doi:10.3390/nu9101087 · Cited by 109
Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis
Takaoka, M., Zhao, X., Lim, H. Y., Magnussen, C. G., Ang, O., Suffee, N., Schrank, P. R., Ong, W. S., Tsiantoulas, D., Sommer, F., et al. (2024) · Nature · doi:10.1038/s41586-024-07993-x · Cited by 116
Szanto, A., Benko, S., Szatmari, I., Balint, B. L., Furtos, I., Rühl, R., Molnar, S., Csiba, L., Garuti, R., Calandra, S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.8154-8166.2004 · Cited by 110
“Handling of lipids by macrophages is an important metabolic process in the context of hypercholesterolemia and the development of atherosclerotic lesions (20, 32, 44).”
BackgroundThe Role of Lipids and Lipoproteins in Atherosclerosis
Linton, M. F., Yancey, P. G., Davies, S. S., Jerome, W. G., Linton, E. F., Song, W., Doran, A. C., & Vickers, K. C. (2015) · Europe PMC (PubMed Central) · Cited by 153
Identification of the Proteoglycan Binding Site in Apolipoprotein B48
Flood, C., Gustafsson, M., Richardson, P. E., Harvey, S. C., Segrest, J. P., & Borén, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204053200 · Cited by 108
Self-citationTran-Lundmark, K., Tran, P.-K., Paulsson-Berne, G., Friden, V., Soininen, R., Tryggvason, K., Wight, T. N., Kinsella, M. G., Boren, J., & Hedin, U. (2008) · Circulation Research · doi:10.1161/circresaha.108.172833 · Cited by 104
Self-citationApolipoprotein B-containing lipoproteins in atherogenesis
Borén, J., Packard, C. J., & Binder, C. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01111-0 · Cited by 120
“SR-B1 seems to have a key role in LDL tran-scytosis by interacting with the guanine nucleotide exchange factor dedicator of cytokinesis protein 4 (DOCK4) 19,20 .”
Self-citationProctor, S. D., Vine, D. F., & Mamo, J. C. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000143859.75035.5a · Cited by 103
Suna, G., Wojakowski, W., Lynch, M., Barallobre‐Barreiro, J., Yin, X., Mayr, U., Baig, F., Lu, R., Fava, M., Hayward, R., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.023381 · Cited by 113
Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review
Wu, M., Liu, L., Xing, Y., Yang, S., Li, H., & Cao, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00118 · Cited by 115
Edsfeldt, A., Nitulescu, M., Grufman, H., Grönberg, C., Persson, A., Nilsson, M., Persson, M., Björkbacka, H., & Gonçalves, I. (2012) · Stroke · doi:10.1161/strokeaha.112.664094 · Cited by 102
“3305 Atherosclerosis is considered an inflammatory disease, initiated by the retention of low-density lipoprotein (LDL) in the arterial subendothelial space.(1) LDL particles, trapped in the vessel wall, undergo modification and induce activation of endothelial cells and recruitment of inflammatory cells through chemo…”
BackgroundAge-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch
Huang, J.-D., Presley, J. B., Chimento, M. F., Curcio, C. A., & Johnson, M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.03.011 · Cited by 114
“…intima is initiated by the ApoB-100 interacting with the sulfate groups of the proteoglycans and further promoted by the oxidative modification of LDL (Williams and Tabas, 1995; Chang et al., 2001; Wang et al., 2001; Skalen et al., 2002; Stocker and Keaney, 2004; Vijayagopal and Menon, 2005).”
BackgroundInfluentialGlycation as an atherogenic modification of LDL
Younis, N., Sharma, R., Soran, H., Charlton-Menys, V., Elseweidy, M., & Durrington, P. N. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328306a057 · Cited by 97
Acidification of the intimal fluid: the perfect storm for atherogenesis
Öörni, K., Rajamäki, K., Nguyen, S. D., Lähdesmäki, K., Plihtari, R., Lee-Rueckert, M., & Kovanen, P. T. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r050252 · Cited by 101
“Especially important is the interaction with proteoglycans (57,58), which initiates LDL retention in the intima (59,60), particularly at the atherosclerosis-prone sites, where the proteoglycan composition favors the retention of apoB-containing lipoproteins (61,62).”
BackgroundElevated Plasma Membrane Cholesterol Content Alters Macrophage Signaling and Function
Qin, C., Nagao, T., Grosheva, I., Maxfield, F. R., & Pierini, L. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000197848.67999.e1 · Cited by 101
ADAMTS proteases in cardiovascular physiology and disease
Santamaria, S., & de Groot, R. (2020) · Open Biology · doi:10.1098/rsob.200333 · Cited by 111
“To support the notion that the direct binding of LDL particles to CSPGs is a key step in atherogenesis, transgenic mice expressing LDL particles where positively charged amino acids in apoBhadbeen replacedwithneutral ones exhibitedsignificantly less atherosclerotic lesions thanmice expressingwild-type apoB [42].”
BackgroundLipoproteins: When size really matters
German, J. B., Smilowitz, J. T., & Zivkovic, A. M. (2006) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2005.11.006 · Cited by 119
Bhaskar, S., Shalini, V., & Helen, A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.07.011 · Cited by 107
NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
Bieghs, V., Rensen, P. C. N., Hofker, M. H., & Shiri‐Sverdlov, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.041 · Cited by 105
“Macrophages can ccumulate large amounts of lipids, transform into foam cells and rive atherogenesis [51–54].”
BackgroundThe Pathogenesis of Atherosclerosis
Cullen, P., Rauterberg, J., & Lorkowski, S. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_1 · Cited by 118
“Retention of LDL within the subendothelial extracellular matrix appears to be necessary for such modifications to occur (Skalen et al. 2002).”
BackgroundRole of smooth muscle cells in Cardiovascular Disease
Zhuge, Y., Zhang, J., Qian, F., Wen, Z., Niu, C., Xu, K., Ji, H., Rong, X., Chu, M., & Jia, C. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.49871 · Cited by 107
“ECM plays a crucial role in initiating atherosclerosis by the interaction between negativecharged proteoglycans and positive-charged apolipoproteins, which causes the retention of plasmaderived lipoproteins [33].”
BackgroundThe Importance of Lipoprotein Lipase Regulation in Atherosclerosis
Kumari, A., Kristensen, K. K., Ploug, M., & Winther, A.-M. L. (2021) · Biomedicines · doi:10.3390/biomedicines9070782 · Cited by 116
“Excessive accumulation of lipoproteins in the subendothelial space leads to fatty streaks, which is a hallmark of early precursor lesions in atherogenesis leading to plaque formation and progression [203,204].”
BackgroundMultiple roles of Toll-like receptor signaling in atherosclerosis
Björkbacka, H. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245258.25387.ec · Cited by 95
Dyslipidaemia in Rheumatological Autoimmune Diseases
Toms, T. E., Panoulas, V. F., & Kitas, G. D. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010064 · Cited by 109
“LDL then undergoes modification and oxidation, inducing the endothelial cells to express leukocyte adhesion molecules [19] and initiating an inflammatory response in the artery wall [20].”
BackgroundImpact of coronary vasa vasorum functional structure on coronary vessel wall perfusion distribution
Gössl, M., Malyar, N. M., Rosol, M., Beighley, P. E., & Ritman, E. L. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00399.2003 · Cited by 97
Talusan, P., Bedri, S., Yang, S., Kattapuram, T., Silva, N., Roughley, P. J., & Stone, J. R. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500088-mcp200 · Cited by 95
Tan, P. H., Chan, C. C. W., Xue, S., Dong, R., Ananthesayanan, B., Manunta, M., Kerouedan, C., Cheshire, N., Wolfe, J. H. N., Haskard, D. O., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.011 · Cited by 95
TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2
Burch, M. L., Yang, S. N. Y., Ballinger, M. L., Getachew, R., Osman, N., & Little, P. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0315-9 · Cited by 94
“The early trapping of LDL in the vessel wall by modified biglycan is the initiating factor in animal models [12, 13] and in human coronary artery M.”
BackgroundNovel Role of ADAMTS-5 Protein in Proteoglycan Turnover and Lipoprotein Retention in Atherosclerosis
Didangelos, A., Mayr, U., Monaco, C. G., & Mayr, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.350785 · Cited by 102
“Following the binding of human LDL on biglycan immobilized on MaxiSorp 96-well immunoplates (NUNC), the wells were covered either with plain MMP buffer or MMP buffer supplemented with 100 pM ADAMTS-5 for 5 h at 37 °C.”
BackgroundMethodInfluentialÖörni, K., Posio, P., Ala-Korpela, M., Jauhiainen, M., & Kovanen, P. T. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168912.42941.60 · Cited by 93
Lee, S., Hur, S., Lee, S. G., Kim, S., Shin, D., Kim, J., Kim, B., Ko, Y., Choi, D., Jang, Y., et al. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001878 · Cited by 92
“Because the endothelium generally acts as a barrier against the excessive uptake of circulating lipids,(25) prolonged exposure to even a modest level of LDL cholesterol may potentially lead to the accumulation of lipids inside the neointima with incompetent endothelium.(26) Higher levels of LDL cholesterol have been r…”
BackgroundTabas, I. A. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308036 · Cited by 100
Hyperelongated biglycan: the surreptitious initiator of atherosclerosis
Little, P. J., Osman, N., & O'Brien, K. D. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830dd7c4 · Cited by 92
Cederholm, A., Svenungsson, E., Jensen-Urstad, K., Trollmo, C., Ulfgren, A.-K., Swedenborg, J., Fei, G.-Z., & Frostegård, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150415.18759.36 · Cited by 93
Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome
Sniderman, A. D., & Faraj, M. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f0dd33 · Cited by 89
Gustafsson, M., Levin, M., Skålén, K., Perman, J., Fridén, V., Jirholt, P., Olofsson, S.-O., Fazio, S., Linton, M. F., Semenkovich, C. F., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.149666 · Cited by 91
Self-citationTriglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0745-6 · Cited by 90
Self-citationZhao, Y., Jia, X., Yang, X., Bai, X., Lu, Y., Zhu, L., Cheng, W., Shu, M., Zhu, Y., Du, X., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155162 · Cited by 92
Hypoxia Increases LDL Oxidation and Expression of 15-Lipoxygenase-2 in Human Macrophages
Rydberg, E. K., Krettek, A., Ullström, C., Ekström, K., Svensson, P.-A., Carlsson, L. M. S., Jönsson-Rylander, A.-C., Hansson, G. I., McPheat, W., Wiklund, O., et al. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000144951.08072.0b · Cited by 89
Self-citationA brief elevation of serum amyloid A is sufficient to increase atherosclerosis
Thompson, J. C., Jayne, C., Thompson, J., Wilson, P. G., Yoder, M. H., Webb, N. R., & Tannock, L. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m054015 · Cited by 95
“Similarly, Skalen et al reported that mice transgenic for human apoB100 in which the proteoglycan binding domain was mutated had decreased early atherosclerosis (37) but not later atherosclerosis (38) suggesting other mechanisms were responsible for late atherosclerosis to develop.”
BackgroundMallat, Z., & Tedgui, A. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00008 · Cited by 99
Dietary fats, cerebrovasculature integrity and Alzheimer’s disease risk
Takechi, R., Galloway, S., Pallebage‐Gamarallage, M. M., Lam, V., & Mamo, J. C. L. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.10.004 · Cited by 94
Song, R., Zeng, Q., Ao, L., Yu, J. A., Cleveland, J. C., Zhao, K.-S., Fullerton, D. A., & Meng, X. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300116 · Cited by 86
RAGE and cardiovascular disease
Shim, C. Y. (2010) · Frontiers in bioscience · doi:10.2741/3700 · Cited by 89
“The oxidized LDLs increases endothelial dysfunction, which may be potentiated by other risk that increase oxidative stress, such as hypertension, smoking and diabetes (2,49,50).”
BackgroundRahman, M. S., & Woollard, K. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_7 · Cited by 101
Serum amyloid A: The “other” inflammatory protein
O’Brien, K. D., & Chait, A. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0066-0 · Cited by 100
“Therapies that specifically target SAA, such as inhibiting its proteoglycan binding domain (as has been done for apoB) [ 74 ], have not been tested.”
BackgroundRoles and mechanisms of puerarin on cardiovascular disease:A review
Jiang, Z., Cui, X., Qu, P., Shang, C., Xiang, M., & Wang, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112655 · Cited by 91
Feng, Y., Schouteden, S., Geenens, R., Duppen, V. V., Herijgers, P., Holvoet, P., Veldhoven, P. P. V., & Verfaillie, C. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047286 · Cited by 97
“Atherosclerosis, the underlying pathogenesis of CHD, is characterized by chronic inflammation due to both loss of endothelial integrity and to subendothelial retention of LDL [4].”
BackgroundTransendothelial transport of lipoproteins
Jang, E., Robert, J., Rohrer, L., von Eckardstein, A., & Lee, W. L. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.020 · Cited by 88
A Murine Model of Obesity With Accelerated Atherosclerosis
King, V. L., Hatch, N. W., Chan, H., de Beer, M. C., de Beer, F. C., & Tannock, L. R. (2010) · Obesity · doi:10.1038/oby.2009.176 · Cited by 82
“This concept is supported by data demonstrating that atherosclerotic lesion formation is attenuated in mice expressing proteoglycanbindingdefective lipoproteins (34).”
BackgroundPircher, A., Treps, L., Bodrug, N., & Carmeliet, P. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.011 · Cited by 89
Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases
Quinn, K. L., Henriques, M., Parker, T., Slutsky, A. S., & Zhang, H. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00472.2008 · Cited by 87
Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?
Williams, K. J., & Fisher, E. A. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200503000-00006 · Cited by 83
Ghesquiere, S. A. I., Gijbels, M. J. J., Anthonsen, M., van Gorp, P. J. J., van der Made, I., Johansen, B., Hofker, M. H., & de Winther, M. P. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400253-jlr200 · Cited by 82
“These mechanisms in turn contribute to prolonged LDL retention and subsequent modifications (38) in the extracellular matrix, resulting in increased atherogenicity of the lipoproteins ( 39 ).”
BackgroundTöröcsik, D., Szanto, A., & Nagy, L. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.02.002 · Cited by 82
Little, P. J., Askew, C. D., Xu, S., & Kamato, D. (2021) · Biomedicines · doi:10.3390/biomedicines9060699 · Cited by 92
Rozenberg, I., Sluka, S. H. M., Rohrer, L., Hofmann, J., Becher, B., Akhmedov, A., Soliz, J., Mocharla, P. S., Borén, J., Johansen, P., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.201079 · Cited by 81
Self-citationCardiovascular Disease Risk Factors
Amani, R., & Sharifi, N. (2012) · InTech eBooks · doi:10.5772/34374 · Cited by 87
Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
Lorey, M. B., Öörni, K., & Kovanen, P. T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.841545 · Cited by 97
Metadata
- Authors
- Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- Gladstone Institutes (US)
- Corresponding author
- Borén, Jan
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6890
- Pages
- 750-754
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083154566
- Cited by
- 1,019
- References
- 28
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 38 · 2023: 42 · 2022: 41 · 2021: 69 · 2020: 48 · 2019: 39 · 2018: 39 · 2017: 29 · 2016: 27 · 2015: 46 · 2014: 42 · 2013: 42 · 2012: 63
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Heart Association
- Research to Prevent Blindness
- Vetenskapsrådet
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherogenesis, apolipoprotein B, apolipoprotein B-100, low-density lipoprotein, proteoglycans, extracellular matrix, sulfate groups, transgenic mice, atherogenic lipoproteins
- MeSH terms
- Animals, Aorta, Apolipoproteins B, Arteriosclerosis, Binding, Competitive, Cholesterol, Diet, Atherogenic, Endothelium, Vascular, Female, Humans, Lipoproteins, Lipoproteins, LDL, Macrophages, Mice, Transgenic, Models, Biological, Mutation, Receptors, LDL, Recombinant Proteins, Triglycerides, Tumor Necrosis Factor-alpha, Amino Acid Substitution, Mice, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.